Amzeal News/10223042

Announcing CHI's Outsourcing for Clinical Trials Conference, April 25-26, 2017, Boston, MA

Perfecting quality partnerships for clinical trial successes.

NEEDHAM, Mass. - March 13, 2017 - Amzeal -- Cambridge Healthtech Institute (CHI) released today the agenda for its second annual Outsourcing for Clinical Trials conference to be held on April 25-26, 2017 at the Westin Copley Place in Boston, MA, as part of the sixth annual Clinical Trial Innovation Summit.

Agenda at-a-Glance:

OUTSOURCING MODELS AND VENDOR SELECTION STRATEGIES

Transactional Outsourcing: Limited Time, Limited Resources, but the Expectations Remain the Same... Get that Study Outsourced
Craig Coffman, Executive Director, Clinical Business Operations & Outsourcing – Development Operations, Nektar Therapeutics

Fit for Purpose Outsourcing – Fulfilling the Varied Needs of Big Pharma
Vatche Kalfayan, Senior Director, Clinical Operations, Pfizer

PANEL DISCUSSION: Avoiding the Blame Game: Defining Deliverables before Selecting Your Vendors

Moderator:

Craig Coffman, Executive Director, Clinical Business Operations & Outsourcing – Development Operations, Nektar Therapeutics

Panelists: Jay Zinni, Associate Director, Procurement, Incyte Pharmaceuticals

Vatche Kalfayan, Senior Director, Clinical Operations, Pfizer
BUDGETING FOR AND CONTRACTING WITH VENDORS AND OUTSOURCED PARTNERS

PANEL DISCUSSION: Contracting Strategies for Today's Clinical Trials
Moderator: Thomas P. Lawler III, MBA, PMP, Founder & Managing Partner, BaywynSolutions, LLC

Budget Forecasting and Tracking: Teamwork and Transparency
Kenneth Olovich, Chief Financial and Procurement Officer, Chorus

Effective Management of Outsourced Site Contract Negotiation
Danielle M. Boram, Esq, MPA, Clinical Contracts Attorney, Associate Director of Contract Management, Clinical Development, ImmunoGen, Inc.

DEVELOPING EFFECTIVE PARTNERSHIPS AND VENDOR RELATIONSHIPS

All About the Base: Developing a Solid Foundation with Our CRO Partners
Barbara Skinn, Ph.D., Operations Portfolio Lead, Global Clinical Operations, Bristol-Myers Squibb

Establishing a Team Atmosphere for Creative Problem Solving|
Thomas P. Lawler III, MBA, PMP, Founder & Managing Partner, BaywynSolutions, LLC

The Importance of Creating Effective Partnership Frameworks When Outsourcing Investigator Site Payments|
Débora Araujo, Associate Director, Clinical Contracting Services, Boehringer Ingelheim Pharmaceuticals, Inc.

Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, lscimemi@healthtech.com.
For details on sponsorship, exhibit and lead generation packages, contact Ilana Quigley, Tel: 781-972-5457, iquigley@healthtech.com.

For more information and to register, visit http://www.clinicaltrialsummit.com/clinical-outsoucing.

About Cambridge Healthtech Institute (CHI)

Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation Bio-IT World Clinical Informatics News and Diagnostics World.

Contact
James Prudhomme
Cambridge Healthtech Institute (CHI)
***@healthtech.com


Source: Cambridge Healthtech Institute

Show All News